A detailed history of Cwm, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 870 shares of RLAY stock, worth $3,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
870
Previous 846 2.84%
Holding current value
$3,680
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$6.23 - $9.51 $149 - $228
24 Added 2.84%
870 $6,000
Q2 2024

Jul 09, 2024

BUY
$5.9 - $8.02 $4,855 - $6,600
823 Added 3578.26%
846 $6,000
Q1 2024

Apr 05, 2024

BUY
$7.5 - $12.07 $172 - $277
23 New
23 $0
Q3 2023

Oct 11, 2023

SELL
$8.24 - $12.97 $3,872 - $6,095
-470 Reduced 95.72%
21 $0
Q2 2023

Aug 03, 2023

BUY
$9.99 - $18.27 $4,905 - $8,970
491 New
491 $6,000
Q3 2022

Oct 27, 2022

BUY
$18.07 - $31.37 $1,969 - $3,419
109 Added 403.7%
136 $3,000
Q2 2022

Jul 28, 2022

BUY
$13.31 - $34.88 $359 - $941
27 New
27 $0

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.